BridgeMD
New treatment option for Pain Management
Official title Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine
ClinicalTrials.gov ID: NCT07416448
What this study is testing
- What it's testing
- This multicenter interventional study in Ukraine is designed to compare the effectiveness of cryoablation and radiofrequency ablation in managing neuroma-associated pain following combat-related trauma. Adult patients with clinically significant neuropathic pain caused by neuromas will be randomly assigned to receive either image-guided cryoablation or radiofrequency ablation of the affected nerve.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Sustained combat-related trauma
- Clinically significant neuroma-associated pain localized to a peripheral nerve or neuroma
- Moderate to severe pain (score ≥ 4 on a standardized numeric pain rating scale)
- Medically stable and able to undergo a percutaneous treatment procedure
You likely can't join if
- Age under 18 years
- Pregnant or breastfeeding
- Severe uncontrolled medical comorbidities that preclude safe participation
- Active infection at or near the proposed intervention site
- Known coagulopathy or use of anticoagulants that cannot be safely withheld
- Previous cryoablation or radiofrequency ablation at the target neuroma within the past 6 months
See the full eligibility criteria
- Age 18 years or older
- Sustained combat-related trauma
- Clinically significant neuroma-associated pain localized to a peripheral nerve or neuroma
- Moderate to severe pain (score ≥ 4 on a standardized numeric pain rating scale)
- Medically stable and able to undergo a percutaneous treatment procedure
- Able to understand and provide written informed consent
- Willing and able to comply with study procedures, including follow-up assessments and patient-reported outcome measures
- May be receiving standard analgesic therapy, including opioids, if usage can be monitored
- No planned surgical intervention at the neuroma site during the study period that could interfere with pain assessment
- Age under 18 years
- Pregnant or breastfeeding
- Severe uncontrolled medical comorbidities that preclude safe participation
- Active infection at or near the proposed intervention site
- Known coagulopathy or use of anticoagulants that cannot be safely withheld
- Previous cryoablation or radiofrequency ablation at the target neuroma within the past 6 months
- Inability to provide informed consent or comply with study procedures
- Participation in another treatment clinical trial that could interfere with study outcomes
- Known allergy or intolerance to materials used during the procedures
The study team makes the final eligibility decision.
Where it's taking place
- Rivne, Ukraine
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rivne, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.